Skip to main content

Table 3 Odds ratios and 95% confidence intervals (CI) for age as predictor of sustained virological response after treatment with peginterferon and ribavirin in 418 chronically HCV infected patients, divided by genotype (133 genotype 1, 285 genotype 2/3)

From: Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study

   Genotype 1 Genotype 2/3
   Odds ratio (95% CI)* Odds ratio (95% CI)*
Age ≤ 45 years 1 1
  > 45 years 0.23 (0.09-0.63) 0.58 (0.33-1.00)
  1. *adjusted for gender, nationality, route of infection, HCV-RNA, ALT, treating department (gastroenterology/hepatology vs. infectious diseases), treatment completion as scheduled, ended before scheduled or dose reduction